decisionhealth Newsletters, Coder Pink Sheets - 2021 Issue 10 (October)
Think twice before you refer patients for urine drug tests
Subscribe or sign in to view the full article.
Article Overview
This article explains why urine drug test referrals can draw Medicare review attention and how practices should think about medical necessity, outside laboratory involvement, and compliance risk. It is aimed at clinicians, coders, and practice leaders who work with drug testing claims and referral patterns. The discussion includes broad guidance on presumptive and definitive drug testing, comparative billing report context, CERT findings, and examples of recent legal actions involving referral-related abuse concerns.
Why This Topic Matters
Urine drug testing is an area with significant billing scrutiny, making referral patterns and test selection important for compliance and audit readiness. Understanding the article helps practices recognize when testing activity may be reviewed and why medically necessary, well-documented ordering matters.
Article Sections
-
Referral and utilization concerns in urine drug testing
Introduces why urine drug testing referrals and outside laboratory use can raise Medicare utilization concerns. Provides context for comparative billing review activity and the compliance environment.
-
Hypothetical referral scenarios
Presents several illustrative situations involving presumptive and definitive drug testing. The section discusses common referral patterns that may trigger scrutiny and broad considerations for medical necessity.
-
CERT report findings and enforcement actions
Summarizes national error-rate reporting and notes recent legal actions tied to drug testing schemes. The section highlights why these services remain an enforcement focus.
-
Compliance reminder for practices
Closes with a reminder that referrals should align with current Medicare guidance and be supported by documentation. Reinforces the broader compliance message of the article.
What You Will Learn
- Why urine drug testing referrals may be reviewed for compliance concerns
- How comparative billing and CERT reporting relate to drug testing oversight
- What broad issues can make drug testing referrals more likely to draw scrutiny
- How recent enforcement activity relates to referral practices and laboratory relationships
Who Should Read This
- Physicians and other ordering clinicians
- Medical coders
- Billing staff
- Compliance officers
- Practice administrators
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com